Comparison of outcomes following subcutaneous or intravenous alemtuzumab administered prior to reduced intensity conditioning for transplantation in pediatric sickle cell disease.
Saved in:
| Title: | Comparison of outcomes following subcutaneous or intravenous alemtuzumab administered prior to reduced intensity conditioning for transplantation in pediatric sickle cell disease. |
|---|---|
| Authors: | Plavsa A; Department of Pediatrics, Creighton University School of Medicine, Phoenix, AZ, USA., Suresh T; Department of Pediatrics, Washington University School of Medicine, St. Louis, MO, United States of America., Dalal S; Department of Pediatrics, Washington University School of Medicine, St. Louis, MO, United States of America., Mirea L; Center for Cancer and Blood Disorders, Phoenix Children's Hospital, Phoenix, AZ, USA., Adams RH; Center for Cancer and Blood Disorders, Phoenix Children's Hospital, Phoenix, AZ, USA., Shenoy S; Department of Pediatrics, Washington University School of Medicine, St. Louis, MO, United States of America., Ngwube A; Department of Pediatrics, Creighton University School of Medicine, Phoenix, AZ, USA; Center for Cancer and Blood Disorders, Phoenix Children's Hospital, Phoenix, AZ, USA. Electronic address: axngwube@texaschildrens.org. |
| Source: | Transplant immunology [Transpl Immunol] 2025 Mar; Vol. 89, pp. 102179. Date of Electronic Publication: 2025 Feb 02. |
| Publication Type: | Journal Article; Comparative Study; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Elsevier Country of Publication: Netherlands NLM ID: 9309923 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-5492 (Electronic) Linking ISSN: 09663274 NLM ISO Abbreviation: Transpl Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1878-5492 |
|---|---|
| DOI: | 10.1016/j.trim.2025.102179 |
